Satellos Bioscience Inc., a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, has appointed Antoinette Paone as Chief Development Officer (CDO) and Head of Regulatory Affairs. Paone brings extensive experience leading regulatory strategy from clinical development through approval, including her work on Kalydeco and Orkambi at Vertex Pharmaceuticals. She joins Satellos from Generation Bio, where she most recently served as Chief Ope...